Atlas Trials

Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia

Clinical trial NCT05606094 · COMPLETED

Trial details

NCT number
NCT05606094
Sponsor
Daiichi Sankyo Co., Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Gastric Cancer
Start date
2023-03-09
Primary completion
2023-11-30
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.